Roche Holding AG (RHHBY) is currently priced at $51.77, marking a positive change of 42 cents (0.818%) from the previous close at $51.35. The trading volume stands at $46,154, representing a 2.04% increase relative to the average volume. Today's performance indicates steady growth, potentially influenced by recent market trends.
In the latest earnings report, Roche Holding AG (RHHBY) revealed an earnings per share of 0.726 for the quarter ending Sunday, June 29th. This figure falls below the consensus estimate of 1.62, suggesting room for improvement in future earnings calls. The company's revenue and earnings call summary data are pending release, awaiting further insights into their financial performance.
Key financial ratios for Roche Holding AG (RHHBY) depict a healthy financial standing. The gross profit margin stands at 72.93%, showcasing strong operational efficiency. Notable ratios include a return on equity of 16.18% and a price-to-earnings ratio of 11.94, indicating a favorable valuation compared to industry peers. The debt-equity ratio of 93.59% and cash flow metrics also highlight the company's balanced financial structure.
This real-time financial snapshot captures Roche Holding AG's resilience in the current market session, underpinned by sound financial metrics and positive trading indicators.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.